Abstract
Biotechnology Law ReportVol. 38, No. 4 As presented by Chris HolmanEndo Pharm. Inc. v. Actavis LLC United States Court of Appeals of the Federal Circuit, 2019 922 F.3d 1365Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN*Published Online:8 Aug 2019https://doi.org/10.1089/blr.2019.29131.cmhAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byThe Market as a Learning Algorithm: Consequences for Regulation and AntitrustSSRN Electronic Journal, Vol. 581 Volume 38Issue 4Aug 2019 InformationCopyright 2019, Mary Ann Liebert, Inc., publishersTo cite this article:Endo Pharm. Inc. v. Actavis LLC United States Court of Appeals of the Federal Circuit, 2019 922 F.3d 1365.Biotechnology Law Report.Aug 2019.243-248.http://doi.org/10.1089/blr.2019.29131.cmhPublished in Volume: 38 Issue 4: August 8, 2019PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
